1. Home
  2. TTGT vs OABI Comparison

TTGT vs OABI Comparison

Compare TTGT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechTarget Inc.

TTGT

TechTarget Inc.

HOLD

Current Price

$3.59

Market Cap

416.4M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$2.33

Market Cap

391.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTGT
OABI
Founded
1999
2012
Country
United States
United States
Employees
N/A
89
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.4M
391.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
TTGT
OABI
Price
$3.59
$2.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$10.75
$4.50
AVG Volume (30 Days)
362.4K
538.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.45
$52.42
Revenue Next Year
$2.75
$64.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.41
$1.32
52 Week High
$9.00
$2.79

Technical Indicators

Market Signals
Indicator
TTGT
OABI
Relative Strength Index (RSI) 34.54 53.16
Support Level $3.52 $1.75
Resistance Level $4.75 $2.79
Average True Range (ATR) 0.23 0.19
MACD -0.01 -0.04
Stochastic Oscillator 7.58 43.92

Price Performance

Historical Comparison
TTGT
OABI

About TTGT TechTarget Inc.

TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: